These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2386927)
21. High dose simvastatin does not reverse resistance to vincristine, adriamycin, and dexamethasone (VAD) in myeloma. van der Spek E; Bloem AC; Sinnige HA; Lokhorst HM Haematologica; 2007 Dec; 92(12):e130-1. PubMed ID: 18055977 [TBL] [Abstract][Full Text] [Related]
22. Treatment of refractory multiple myeloma with vincristine, adriamycin, dexamethasone, and with repeated application of cyclophosphamide (C-VAD). Adam Z; Elbl L; Vorlicek J; Hájek R; Hájek D; Hejlová N; Králová E; Novotná H Acta Med Austriaca; 1994; 21(4):111-5. PubMed ID: 7871966 [TBL] [Abstract][Full Text] [Related]
23. Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies. Mundt AJ; Rotmensch J; Waggoner S; Quiet C; Fleming G Gynecol Oncol; 1999 Jan; 72(1):45-50. PubMed ID: 9889028 [TBL] [Abstract][Full Text] [Related]
24. Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study. Sonneveld P; Marie JP; Huisman C; Vekhoff A; Schoester M; Faussat AM; van Kapel J; Groenewegen A; Charnick S; Zittoun R; Löwenberg B Leukemia; 1996 Nov; 10(11):1741-50. PubMed ID: 8892677 [TBL] [Abstract][Full Text] [Related]
25. [Extensive vaginal carcinoma with total prolapse--a therapeutic problem]. Meier HM; Schopohl B Zentralbl Gynakol; 1995; 117(3):160-3. PubMed ID: 7740852 [TBL] [Abstract][Full Text] [Related]
26. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial. Kim HJ; Yoon SS; Lee DS; Sohn SK; Eom HS; Lee JL; Chung JS; Kim K; Suh C; Won JH; Kim JS; Park JS; Kang HJ; Seong CM; Kim CS; Lee SJ; Lee JH Ann Hematol; 2012 Feb; 91(2):249-56. PubMed ID: 21789621 [TBL] [Abstract][Full Text] [Related]
27. [Lower cardiotoxicity of adriamycin during continuous administration in patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone (C-VAD)]. Adam Z; Elbl L; Vorlícek J; Hájek R; Tomíska M; Hejlová N; Králová E; Novotná H Vnitr Lek; 1994 Aug; 40(8):506-12. PubMed ID: 7941437 [TBL] [Abstract][Full Text] [Related]
28. Bilateral ureteral obstruction secondary to condylomata acuminata of the urinary bladder. Ginsberg PC; Williams JJ; Klaus RL J Am Osteopath Assoc; 1989 Jan; 89(1):69-72. PubMed ID: 2646251 [TBL] [Abstract][Full Text] [Related]
33. [Pleural effusion in multiple myeloma]. Ballesteros del Río B; Barbón Fernández M; Muela Molinero A; Sánchez Real Linacero J An Med Interna; 2007 Jun; 24(6):306-7. PubMed ID: 17944046 [No Abstract] [Full Text] [Related]
34. [Incoercible hematuria due to prolonged treatment with cyclophosphamide]. Scetbon V J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):472-6. PubMed ID: 4804422 [No Abstract] [Full Text] [Related]
36. [Ambulatory therapy of multiple myeloma with vincristine, adriamycin and dexamethasone]. Egerer G; Hegenbart U; Salwender H; Hahn U; Haas R; Goldschmidt H; Hunstein W Dtsch Med Wochenschr; 1997 Apr; 122(17):531-5. PubMed ID: 9190299 [TBL] [Abstract][Full Text] [Related]
37. [Improved prognosis of generalized AL-amyloidosis in a patient with multiple myeloma treated according to the VAD protocol]. Sarkisova IA; Rameev VV; Kozlovskaia LV; Andreeva NE Ter Arkh; 2003; 75(8):81-2. PubMed ID: 14520860 [No Abstract] [Full Text] [Related]
38. The VAD-DCEP sequence is an effective pre-transplant therapy in untreated multiple myeloma. Corso A; Barbarano L; Zappasodi P; Cairoli R; Alessandrino EP; Mangiacavalli S; Ferrari D; Fava S; Fiumanò M; Frigerio G; Isa L; Luraschi A; Klersy C; De Paoli A; Vergani C; Banfi L; Perego D; Ucci G; Pinotti G; Savarè M; Uziel L; Vismara A; Morra E; Lazzarino M Haematologica; 2004 Sep; 89(9):1124-7. PubMed ID: 15377474 [TBL] [Abstract][Full Text] [Related]
39. [Comparative evaluation of treatment results in advanced multiple myeloma with the help of polychemotherapy with vincristine, doxorubicin, dexamethasone (VAD) or only with dexamethasone]. Hansz J; Włodarczyk M; Psuja P Acta Haematol Pol; 1992; 23(4):277-84. PubMed ID: 1293910 [TBL] [Abstract][Full Text] [Related]